Background-Arrhythmias associated with QT prolongation on the ECG often lead to sudden unexpected death in epilepsy.
H uman mortality associated with epilepsy in North
America is 21% to 22%. 1 ECG abnormalities occur in 35% of generalized seizures [2] [3] [4] and are characterized by cardiac rhythm and repolarization changes. 3, 5 Sudden death caused by epilepsy (SUDEP) accounts for 17% of all epilepsy-related casualties. Clinical evidence has linked SUDEP to arrhythmias 1 associated with different conditions, including conduction block 3, [5] [6] [7] and prolongation of the QT interval on the ECG, 6,7 the latter being an indication of a prolonged action potential. These causes of arrhythmias are commonly associated with alterations of the cardiac sodium current I Na . The rat model of epilepsy used in this study faithfully reproduces these cardiac arrhythmias. 8, 9 Editorial see p 769 I Na displays the following 3 phases: (1) a fast activating component responsible for the peak inward (depolarizing) current associated with the peak of the action potential, (2) rapid inactivation of most of the peak current, and (3) a sustained late component (I NaL ). In most cases, conduction disturbances are associated with alterations of peak I Na . The high density of fast Na channels (Na V s) within the ventricles and His-Purkinje system insures a rapid initial depolarization rate during an action potential (AP) and, thereby, a rapid conduction velocity. The voltage dependence of I Na activation determines excitability. Therefore epilepsy-induced changes in the activation voltage of I Na could explain changes in cardiac conduction and excitability. The duration of the QT interval, however, is mostly determined by a balance between the inward late sodium current (I NaL ) that tends to lengthen the AP duration (APD) and the outward potassium currents that tend to shorten APD. An increase in I NaL will therefore have a tendency to prolong the QT interval. The important role of I NaL in regulating repolarization time is highlighted by studies of long-QT syndrome, [10] [11] [12] the use of ranolazine (a I NaL blocker) to treat arrhythmias, [13] [14] [15] and by early experiments showing that application of low concentrations of the sodium channel blocker tetrodotoxin (TTX) shortens APD. 16 This latter result is explained by the much higher affinity of the neuronal isoforms of the Na channel for TTX compared with the primary isoform in cardiomyocytes (Na V 1.5).
Recent findings indicate that expression of neuronal sodium channel isoforms (nNa V s) in the rat hippocampus increases during epilepsy. 17, 18 This enhanced expression of TTX-sensitive Na V s is thought to potentiate seizures by increasing I NaL and by also increasing excitability in brain cells. Missense mutations in Na V 1.1 and Na V 1.2 that increase I NaL amplitude [19] [20] [21] in hereditary epilepsy seem to confirm this hypothesis. However, epilepsy patients display prolonged QT interval and enhanced expression of Na V 1.1 even in absence of mutations in neuronal Na V s. 22, 23 These observations raise the possibility that, as in the brain, epilepsy enhances expression of TTX-sensitive Na V s in cardiac cells thereby modifying their excitability and increasing I NaL . In the heart, we showed that an increase in I NaL is associated with long-QT syndrome 10, 11, 24 and sudden death. In this study, we wanted to test the hypothesis that upregulation of nNa V s channels may, in part, explain the cardiac arrhythmias associated with the increased risk of SUDEP in epileptic patients.
Our results indicate that ventricular APs are longer in epileptic rats because of a TTX-sensitive increase in I NaL amplitude. Epilepsy also resulted in an increased contribution of TTX-sensitive channels to peak I Na , a reduced activation threshold, and a slower recovery from inactivation. All of these effects on I Na can be explained by an increase in neuronal Na-channel expression levels. Consistent with this possibility, we report here that epilepsy was associated with enhanced expression of the neuronal sodium channel isoform Na V 1.1 in cardiac cells. Overall, our study confirms the important role of neuronal sodium channels in establishing the duration of the cardiac action potential, and our results indicate that epilepsy-related arrhythmias and SUDEP are likely because of enhanced expression of these channels.
Methods

Animal Model
We used the kainic acid (KA)-induced epilepsy model which is the most widely used model to study chronic epilepsy. Briefly, adult male Sprague-Dawley rats weighing between 200 and 250 g were housed 1 per cage on a 14-hour/10-hour light/dark cycle, with free access to food and tap water. Seizures were induced by intraperitoneal injection of KA (12 mg/kg). This proconvulsant agent was injected (intraperitoneally) and the status epilepticus was stopped 2 hours after KA injection with diazepam (25 mg/kg; IP). Status epilepticus is characterized by limbic seizures which start 10 to 15 minutes after KA injection. Only animals showing seizure behavior consisting of rearing or rearing and falling, which correspond to stages 4 to 5 on the Racine scale 25 ,were used for this study. Control animals (sham) received diazepam and saline in lieu of KA. All animals were used between 36 and 40 days after treatment.
Cell Dissociation
Ventricular myocytes from adult rats were isolated by enzymatic dissociation as previously described. 26, 27 Electrophysiology APs were measured using the perforated patch technique with amphotericin (Sigma; 6 mmol/L) as the ionophore. 28 For AP measurements, cardiomyocytes were superfused at room temperature with a solution containing (in mmol/L): 126 NaCl, 5.4 KCl, 2.0 CaCl 2 , 1.0 MgCl 2 , 20 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), and 11 glucose (pH 7.4 with NaOH). Pipette solution contained in mmol/L: 90 K-aspartate, 30 KCl, 10 NaCl, 5.5 glucose, 1.0 MgCl 2 , 10 ethylene glycol tetraacetic acid (EGTA), 4 Na 2 -ATP, 10 HEPES (pH 7.2 with KOH). The I to specific blocker 4-aminopyridine (4 mmol/L) was used where indicated. Tip potential cancellation procedure, methodological considerations, and quality selection criteria are described in the Data Supplement. I Na was measured at room temperature using the patch clamp technique in voltage-clamp mode as previously described. 27 The extracellular solution contained (in mmol/L): 125 choline-Cl, 2.5 NaCl, 2.5 NaOH, 2.8 Na acetate, 4 KOH, 0.5 CaCl 2 , 1.5 MgCl 2 , 20 HEPES, and 10 glucose (pH 7.4 with NaOH). The concentration of Na + was reduced to 7.8 mmol/L to prevent loss of voltage control during I Na measurements. Tetraethyl ammonium (5 mmol/L), CoCl 2 (1 mmol/L), and BaCl 2 (5 mmol/L) were used to block I to , I CaL , and I K1 currents, respectively. For I NaL recordings, perfusion solution contained (in mmol/L): 125 NaCl, 5 NaOH, 2.8 Na acetate, 4 KOH, 0.5 CaCl 2 , 1.5 MgCl 2 , 20 HEPES, and 10 glucose (pH 7.4 with NaOH). For both I Na and I NaL recordings, the patch pipette (1-3 MΩ) solution contained (in mmol/L): 15 NaCl, 5 KCl, 120 CsF, 1.0 MgCl 2 , 4 Na 2 -ATP, 10 EGTA, and 10 HEPES (pH 7.2 with CsOH). All solutions were adjusted at 300 mOsm with sucrose. Data acquisition and analysis were performed using the pCLAMP program suite V9.2 (Axon instruments).
Dose-Response Curve Analysis
The dose-response curve was obtained using a sum of 2 Langmuir isotherms I Na,TTX /I Na,Ctrl =ƒ TTXs {1/(1+[TTX]/IC 50/ƒTTXs )}+(1−ƒ TTXs )
WHAT IS KNOWN
• Human mortality associated with epilepsy in United States and Canada is 21% to 22%. Sudden unexpected death during epilepsy accounts for 17% of all epilepsy-related casualties and is associated with cardiac arrhythmias, such as heart rhythm disturbances and prolongation of the QT interval on the ECG (an index of the ventricular action potential duration).
• The mechanisms leading to prolongation of the QT interval are unknown but the duration of the cardiac action potential and QT is governed by a fine balance of outward potassium currents and, among others, the late sodium current.
WHAT THE STUDY ADDS
• Epilepsy induces a molecular remodeling of the cardiac ventricle characterized by expression of neuronal type sodium channels (nNa V s).
• Overexpression of the nNa V s lead to a significant augmentation of the late sodium current thus favoring prolongation of the action potential duration and arrhythmias.
• This represents a new paradigm in our understanding of sudden unexpected death during epilepsy whereby arrhythmias are not centrally mediated (brain) as currently thought but result from adaptive cardiac defects.
{1/(1+[TTX]/IC 50/ƒTTXr )} fitted to data. The 50% blocking concentration of TTX-sensitive channels (IC 50/ƒTTXs ) was determined by fitting data points between 0.1 and 100 nmol/L TTX with the absorption isotherm: I Na,TTX /I Na,Ctrl =ƒ TTXs {1/(1+[TTX]/IC 50/ƒ TTXs )} with ƒ TTXs defined as the fraction of TTX-sensitive channels given by difference between 100% and the value of the plateau observed at 30 nmol/L which blocks essentially all of the TTX-sensitive and almost none of the cardiac isoform of the Na channel (which is blocked at much higher concentrations of TTX). The ƒ TTXs and IC 50/ƒTTXs values were then used as seed value to fit the entire curve keeping the assumption of a 1:1 binding of TTX to all receptors.
Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction
Sodium channel cDNA was measured as previously published. 29, 30 Total RNA was isolated (Total RNA Isolation Kit, Ambion) and reverse transcribed (RT) using Superscript II (Invitrogen). One μg of RT-cDNA was used as template for the amplification. Primers specific to each of the rat Na V isoforms tested were used to amplify fragments. Each amplicon was subcloned into pUC119 for sequencing and for amplification efficiency controls. Real-time PCR was performed using the Rotor-Gene 3000 Cycler from Corbett Research (United States) with the Platinum SYBR Green Kit (Invitrogen). The specificity of the PCR reactions was verified by sequencing of the amplicon. The amount of cDNA in each reaction was calculated by comparing the results with calibration curves obtained by simultaneous amplification of known concentrations of a construct containing the amplicon of each gene in pUC119 using the Comparative Quantification feature of the Rotor-Gene software. β-actin served as an endogenous control for loading of the cDNA sample. Each experiment was repeated 4× for SCN5A and 3× for SCN1A. PCR was performed in triplicate for each sample.
Western Blot Analysis
Myocardial extracts were prepared through homogenization of dissected ventricles (left and right) as described previously. 27, 30 Proteins from the plasma membrane, cytosolic, and endosomal fractions were separated by centrifugation at 5000 to 10 000g, 20 000g, and 100 000g, respectively, as previously described by us 27, 31 and others, 32 and 100 µg of proteins from the plasma membrane fraction was used in the Western blot assay. Detection was performed using the following primary antibodies at a dilution of 1:200: SP19 antipan sodium channel (ACS-003, Alomone Laboratories), Na V 1.5 (ASC-013, Alomone), Na V 1.1 (ab24820, Abcam), and Calnexin (Abcam). Horseradish peroxidase-conjugated antirabbit (1:5000; Cell Signaling) was used as secondary antibody.
Statistics
Data are expressed as mean±SEM (SE of the mean). Statistics were performed using a Student t test on paired data. Data that could not be paired were pooled. We therefore had 2 variables (factors) such as type of animal and concentration of TTX to take into account and a 2-way ANOVA was performed in those cases. When applicable (Figures 1-3 ), statistical significance was verified by a second test (Kruskal-Wallis, standard χ 2 ). In all cases, the second tests confirmed the validity of the 2-way ANOVA.
Study Approval
All animal protocols, care, and maintenance were approved by the ethics review board of the Faculty of Medicine of the Université de Sherbrooke and follow the ARRIVE guidelines (Animal Research: Reporting of In vivo Experiments).
Results
Epileptic patients have longer QT intervals (indicating longer ventricular action potential) which have been associated with SUDEP. As seen in Figure 1 , our epileptic rat model reproduced the increased APD observed in human epileptic patients ( Figure 1 ). Application of 4-aminopyridine (4-AP) to eliminate the contribution of the transient outward potassium current (I to ) further prolonged the APD in epileptic animals thus confirming an increased contribution of depolarizing currents to APD. We next assessed whether the prolongation of APD during epilepsy was because of an increase in I Na using TTX, a specific blocker of sodium channels that has a much higher affinity for binding and blocking neuronal sodium channels compared with the main cardiac Na channel ( Figure 2 ). TTX was more potent at reducing the APD in epileptic animals. In control conditions and following perfusion with 4-AP, a TTX concentration of 1 nmol/L reduced the APD 30 (measured at 30% repolarization) in epileptic rats but not in sham cardiomyocytes ( Figure 2C ). This effect on cardiomyocytes from epileptic rats was more pronounced in the presence of 4-AP, whereas those from sham animals showed no significant reduction in APD 30 with 1 or 50 nmol/L TTX ( Figure 2D ). These results indicate an increased contribution of TTX-sensitive sodium channels in cardiomyocytes from epileptic rats.
We next compared properties of I Na in sham and epileptic animals ( Figure 3 ). The maximum amplitude of I Na was increased by 18±6%, from −75±5 pA/pF in sham ventricular myocytes to −92±6 pA/pF ( Figure 3C ) in those from epileptic rats. In addition, myocytes from epileptic rats were more excitable as indicated by a ≈5 mV negative shift in I Na activation threshold ( Figure 3B ). The mid-activation potentials (V 1/2 ) give a more quantitative value associated with this shift ( Figure 3D ); this value shifted from −42.8±0.3 mV in myocytes from sham animals to −48.6±0.3 mV in those from epileptic rats. There was no significant difference in the maximum conductance (G Na,Max ; Figure 3E ). These changes indicate that I Na activates at voltages closer to the resting membrane potential during epilepsy indicating greater excitability in ventricular cardiomyocytes from epileptic rats.
We next tested if an increase in the availability of the sodium channels could explain the gain in I Na amplitude associated with epilepsy. However, this does not seem to be the case because the availability of I Na shifted by only 2 mV during epilepsy, from a mid inactivation voltage of −81.8±0.1 mV in sham animals to −83.8±0.1 mV in epileptic animals ( Figure 4 ). Although significant (P<0.05, t test), this change is in the wrong direction because hyperpolarizing steady-state inactivation will reduce the number of sodium channels available at resting membrane potential. This last result combined with the observations of a shift in activation of the channel without significant changes in the maximum conductance suggests that epilepsy altered the gating of channels responsible for I Na rather than increasing their number. These results combined with data presented in Figure 2 indicate that a shift of the sodium channel population toward TTX-sensitive channels might be responsible for the changes observed in APD and I Na . To test this hypothesis, we assessed the sensitivity of I Na to low doses of TTX. Figure 5A shows that cardiomyocytes from epileptic rats are more sensitive to TTX. Cells from both sham and epileptic animal show a biphasic TTX dose response with a plateau for concentrations between 30 and 300 nmol/L ( Figure 5B ). The amplitude of I Na increased during epilepsy. A, Typical recordings of I Na in sham and epileptic animals during a depolarization to −30 mV from a holding potential of −120 mV (inset). B, Current-voltage relationship following stimulations from −90 to +40 mV in 5-mV increments from a holding potential of −120 mV. Peak currents were normalized to cell capacitance (pA/pF). C, Average maximum peak current density. D, Voltage dependence of activation of I Na . Sodium conductance G Na was calculated as the ratio of I Na /(V m −E Na ), where V m represents the membrane test potential and E Na represents the reversal potential for I Na . G Na was then normalized to the maximum conductance (G Na,max ) for each individual cell and data were averaged to yield the activation curve. Data were fitted to a standard Boltzmann distribution. Half-activation potential was hyperpolarized during epilepsy (P<0.05, F test from ANOVA). E, Maximum conductance obtained from the slope of the linear portion of the I/V curve presented in A. Sham: n=21. Epileptic: n=35. *P<0.05 vs sham. However, epilepsy was associated with a lower plateau level thus indicating that a larger fraction of Na + channels was blocked at low TTX concentrations. To emphasize this aspect of the TTX block, we analyzed our measurements using a sum of 2 Langmuir isotherms (see Methods) assuming a 1:1 binding ratio of TTX to TTX-sensitive (ƒ TTXs ) and TTX resistant (ƒ TTXr ) receptors. The TTX concentrations of half-maximal block (IC 50/TTX ) obtained from the fit to data were not different between cells from sham and epileptic animals with respective values of 1100 and 1250 nmol/L for the TTX-resistant and 5.3 and 2 nmol/L for the TTX-sensitive channels, respectively. The plateau observed at the lower concentration of TTX in the dose-response curve ( Figure 5B ) dropped from 76±3% to 65±4% indicating an 11% increase in ƒ TTXs during epilepsy. The increase in the fraction of I Na blocked by low concentration of TTX in epileptic animals is consistent with an augmentation of TTX-sensitive channels (IC 50 ≈ 2-5 nmol/L) 33 without significant effect of the cardiac sodium channel isoform Na V 1.5 (IC 50 ≈2-5 μmol/L). This result therefore indicates an increased contribution of TTX-sensitive channels to I Na .
The late component of I Na (I NaL ) is known to modulate APD. As seen in Figure 6 , I NaL was measured by subtracting the current measured at the end of a 300-ms test pulse in the presence of 25 μmol/L TTX (inhibiting all of I Na ) from that measured in the absence of TTX. I NaL density increased from 1.5±0.2 pA/pF in sham animals to 2.3±0.3 pA/pF during epilepsy. Application of 1 nmol/L TTX to block TTX-sensitive channels reduced the amplitude of I NaL more importantly in myocytes from epileptic animals (1.12 pA/pF) versus sham (0.52 pA/pF). Following application of 1 μmol/L, the amplitude of I NaL in cells from sham and epileptic animals were reduced to the same level. However, because I NaL amplitude was larger in epileptic rats, TTX reduced I NaL by 75±15% versus 59±16% in sham cells ( Figure 6B ), thus indicating a larger contribution of TTX-sensitive channels during epilepsy.
TTX-sensitive (brain type) and TTX-resistant (cardiac type) sodium channels differ by their activation voltage. TTXresistant channels (Na V 1.5) are largely activated between −60 and −30 mV, whereas TTX-sensitive channels are not fully activated in that range of potentials. 29, [34] [35] [36] However, at −10 mV, all channels are activated. Therefore, a contribution of TTX-sensitive channels to I NaL should translate in a smaller amount of block by TTX at −30 mV compared with the one measured at −10 mV. In agreement, Figure 7 shows that 1 nmol/L and 1 μmol/L TTX blocked a larger portion of I NaL at voltages above −30 mV, thus creating an inflection point at −35 mV in the sham current-voltage relationship. Compared with sham myocytes, TTX blocked a larger portion of I NaL at −30 mV in epileptic rats but blockade remained more pronounced at −10 mV, consistent with an increased contribution of TTX-sensitive channels.
Previous studies have reported that epilepsy increases the amplitude of I NaL in rat brains [37] [38] [39] by enhancing expression of TTX-sensitive channels, including Na V 1.1 in rat hippocampus. 17, 18, 40 To verify if epilepsy was also associated with an increased expression of Na V 1.1 in the heart, we measured the amount of SCN1A and SCN5A cDNA, respectively, coding for the α-subunit of Na V 1.1 and Na V 1.5. Quantitative realtime RT-PCR experiments ( Figure 8A ) using specific primers to each gene show a significant increase (49%) in expression of the Na V 1.1 cDNA in hearts from epileptic animals. Surprisingly, cDNA for Na V 1.5 was however reduced by 54% during epilepsy. However, no difference in expression of either gene was observed between sham-operated and control animals (no injections). To correlate these results with changes in expression of sodium channels, we performed Western blot experiments on proteins extracted from the plasma membrane of ventricular myocytes. Figure 8B shows that overall expression of sodium channel proteins (SP19), including Na V 1.5 and Na V 1.1, was increased during epilepsy. Changes in the expression of sodium channels were determined by densitometric measurements of each band and comparison with the loading control calnexin ( Figure 8C) . Detection with the antipan SP19 antibody showed a trend to increase overall expression of sodium channels but the difference between sham and epileptic animals did not reach a significance level (P=0.06) within the number of animals used (n=6). However, expression of Na V 1.1 and Na V 1.5 was significantly increased in epileptic animals.
Conduction block is a frequent occurrence in epilepsy and can be caused by an increase in the heart refractory period because of delayed recovery of I Na from inactivation. In agreement, we found that epilepsy was associated with a longer I Na recovery (P<0.05, Figure in the Data Supplement). A sum of 2 exponentials fitted to data yielded time constants of 14.0±0.2 ms (85%) and 63.2±8 ms (15%) in sham animals and 18.4±0.2 ms (84%) and 119±6 ms (14%) in epileptic rats. This result indicates that an increased refractory period may contribute to conduction anomalies during epilepsy.
Discussion
Our measurements indicate that epileptic conditions increase I Na peak amplitude by 18±6% and hyperpolarized its threshold voltage by 6 mV in cardiac ventricles. These changes are strikingly similar to the findings of Guo et al 18 who reported a 16% increase and a negative shift of 7 mV in steady state activation of I Na in the hippocampus of epileptic rats. In brain, these gating alterations were mostly attributed to enhanced expression of nNa V s isoforms, Na V 1.1 and Na V 1.2. 17, 40 Results in this article combined with our earlier study showing the presence of neuronal TTX-sensitive sodium channels within the heart 41, 42 led to our hypothesis that a common mechanism is responsible for increasing the expression of nNa V s in both brain and heart during epilepsy.
Our RT-PCR and Western blot analysis confirmed that both cDNA and protein expression of Na V 1.1 are enhanced in the heart. This direct correlation between the change in mRNA and protein level suggests that epilepsy is acting at the genomic level to promote expression of neuronal channels. One puzzling observation ( Figure 8 ) was a decreased amount of Na V 1.5 mRNA but a doubling of the expressed protein in cells from epileptic animals. One potential explanation is that reduction in Na V 1.5 mRNA is compensated by a slower internalization (recycling) of the mature proteins expressed at the surface of cardiomyocytes. Thus, epilepsy may act by directly altering gene expression and protein trafficking, perhaps by prolonging Na V 1.5 half-life at the plasma membrane. Na V 1.2 is another neuronal channel involved in epilepsy, however, it does not seem to be expressed in the cardiac ventricle of rodents. [42] [43] [44] Consistent with these observations, we could not detect Na V 1.2 mRNA in rat ventricle (data not shown).
Our measurements with the SP19 antibody indicated a trend to increase overall expression of sodium channels (P<0.06) in the plasma membrane ( Figure 8B ). This translated into a rather modest augmentation of I Na peak current ( Figure 3A-3C) . Although the semiquantitative nature of Western blot measurements preclude a direct correlation with the number of functional proteins participating to I Na , these results nonetheless suggest that cellular mechanisms altering the gating of other Na V s are contributing to limit the increase in I Na during epilepsy. Moreover, epilepsy did not change I Na maximal conductance G Na,Max , thus indicating that the overall number of channels contributing to I Na remained the same. Changes in activation voltage (Figure 3 ) because of enhanced expression of sodium channels having slightly different biophysical properties may, in part, explain the increase in I Na amplitude, a hypothesis supported by our results showing that epilepsy is associated with increased expression of TTX-sensitive channels. Recent findings also suggest that phosphorylation of sodium channels by calmodulin kinase II (CaMKII) also contribute to modulation of I Na amplitude in epileptic brain. 40 Whether a similar mechanism also exists in epileptic heart remains to be determined.
Despite the absence of alteration in G Na,Max arguing against a net increase in the total number of sodium channels participating to I Na , the TTX dose-response curve we obtained clearly indicate an augmentation of the contribution of TTXsensitive channels during epilepsy. At first glance, the contribution of TTXs-Na V s to I Na during epilepsy seems relatively modest (≈25%, Figure 5B ) and makes it difficult to conceive that this alone could trigger cardiac arrhythmias ultimately leading to SUDEP. However, TTX-sensitive channels contribute much more significantly to the late sodium current. 41 This larger contribution to I NaL can be explained from the fact that the fraction of persistent current to peak current is 10 times larger for TTXs-Na V s compared with Na V 1.5; ranging from 0.05 to 0.13 for TTXs-Na V s and 0.002 to 0.005 for Na V 1.5. 10, 41, [45] [46] [47] [48] Our study revealed that I NaL increased by 30±2% during epilepsy. Consistent with the contribution of TTXs-Na V s to I Na peak, application of 1 nmol/L TTX (a concentration ≈1000fold less than the Kd for Na V 1.5 channels) blocked 49±3% of I NaL in epileptic rat myocytes versus 35±2% in sham cells ( Figure 6 ). Because of the larger I NaL in epileptic animals, this translated into a doubling of the density of the TTX-sensitive current from 0.52 pA/pF in sham to 1.12 pA/pF in epileptic rat myocytes. With 1 μmol/L TTX, the amplitude of I NaL in sham and epileptic rat myocytes were reduced by 59±16% and 75±15%, respectively, but the final amplitudes were not different, indicating no change in the number of TTX-resistant Na channels because only TTX-resistant channels contribute to I NaL after application of 1 μmol/L TTX. Further support for an important contribution of TTXs-Na V s to I NaL during epilepsy comes from the high sensitivity of I NaL to TTX in a range of membrane potentials where TTX-s Na V s are maximally activated (V m > −30 mV, Figure 7 ). In summary, the I NaL measurements are consistent with an enhanced expression of TTX-sensitive Na V s and no change in TTX-resistant Na V s.
The important role of I NaL in regulating repolarization time and QT interval is exemplified by studies of long-QT syndrome [10] [11] [12] or the use of ranolazine (a I NaL blocker) to treat arrhythmias in myocardial ischemia and atrial fibrillation [13] [14] [15] 49 and early experiment showing that specific sodium channel blocker TTX shortens normal APD. 16 Severe prolongation of the ventricular repolarization time is associated with a longer QT interval on the ECG and lethal torsade de pointe arrhythmias as well as conduction anomalies all of which can result in sudden death. Our results show that epilepsy correlated with an increase in I NaL amplitude which likely explained the prolongation of the APD 30 by ≈20% (Figure 1) . In human, a similar effect would increase the APD from a standard value of 440 to 528 ms, the latter well within the arrhythmogenic range, which would explain the epilepsy-induced prolongation of the QT interval observed in humans. 6, 7, 50 We were able to demonstrate that epilepsy was associated with an increase in I NaL contributing to the plateau of the action potential. This was confirmed by application of TTX at low concentration which produced a greater reduction in the APD in epileptic rat cells compared with control cell (Figure 6 ).
Conduction anomalies are also observed in epilepsy. 3,5-7 Conduction velocity and the ventricular contraction rate depend on the time needed for I Na to recover from inactivation between APs, the so-called refractory period of the heart. Prolongation of I Na recovery time (Figure in the Data Supplement) because of changes in the biophysical properties of the sodium channels will prolong the refractory period and may lead to conduction anomalies such as skipped heartbeat or bradycardia similar to the ones observed during epilepsy. Longer APDs allowing a greater fraction of sodium channels to become inactivated will further potentiate the influence of I Na recovery on conduction. Our results show that I Na recovery from inactivation is slower in epileptic animals. Therefore, the combined effects of epilepsy on APD and the slower recovery of I Na are likely to increase the risk of conduction disturbances during epilepsy.
We show for the first time that epilepsy alters cardiac I Na and I NaL in a manner consistent with QT prolongation and conduction anomalies observed clinically. Previous studies have shown that epileptic conditions enhance expression of Na V 1.1 and its contribution to I NaL in the brain hippocampus. A new finding also reported here is that overexpression of Na V 1.1 in epileptic cardiomyocytes may also play a role in these effects on I NaL . This suggests that similar but yet unknown adaptation mechanisms to epilepsy exist in the brain and the heart. Our results also raise the possibility that systemic changes in neurotransmitter levels or other signaling process during status epilepticus are acting as a trigger for overexpression of TTXs-Na V s in both tissues and this contributes to cardiac arrhythmias observed during epilepsy in humans. 17, 18 Based on our findings, we propose a new paradigm whereby an increased contribution of neuronal sodium channels alters the conduction properties of cardiomyocytes and the cardiac ventricular action potential duration both of which can contribute to the known risk of epileptic patients to SUDEP. 
